Centers for Medicare and Medicaid Services (CMS) Issues Permanent J-Code for Tolmar's FENSOLVI(R) Effective July 1, 2021

BUFFALO GROVE, Ill., May 12, 2021 -- (Healthcare Sales & Marketing Network) -- Tolmar Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a new product-specific ... Biopharmaceuticals, Reimbursement Tolmar Pharmaceuticals, FENSOLVI, leuprolide, Central Precocious Puberty
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news